These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8602742)

  • 1. Postmortem and cerebrospinal fluid studies of corticotropin-releasing factor in humans.
    Hartline KM; Owens MJ; Nemeroff CB
    Ann N Y Acad Sci; 1996 Mar; 780():96-105. PubMed ID: 8602742
    [No Abstract]   [Full Text] [Related]  

  • 2. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia.
    Banki CM; Bissette G; Arato M; O'Connor L; Nemeroff CB
    Am J Psychiatry; 1987 Jul; 144(7):873-7. PubMed ID: 3496802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiology and pharmacology of corticotropin-releasing factor.
    Owens MJ; Nemeroff CB
    Pharmacol Rev; 1991 Dec; 43(4):425-73. PubMed ID: 1775506
    [No Abstract]   [Full Text] [Related]  

  • 4. Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients.
    Gerner RH; Yamada T
    Brain Res; 1982 Apr; 238(1):298-302. PubMed ID: 6123376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression.
    Kaye WH; Gwirtsman HE; George DT; Ebert MH; Jimerson DC; Tomai TP; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1987 Feb; 64(2):203-8. PubMed ID: 3491830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid corticotropin-releasing hormone in neurodegenerative diseases: reduction in spinocerebellar degeneration.
    Suemaru S; Suemaru K; Kawai K; Miyata S; Nobukuni K; Ihara Y; Namba R; Urakami K; Hashimoto K
    Life Sci; 1995; 57(24):2231-5. PubMed ID: 7475976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients.
    Nemeroff CB; Widerlöv E; Bissette G; Walléus H; Karlsson I; Eklund K; Kilts CD; Loosen PT; Vale W
    Science; 1984 Dec; 226(4680):1342-4. PubMed ID: 6334362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal-fluid neuropeptides: a biochemical subgrouping approach.
    Banki CM; Karmacsi L; Bissette G; Nemeroff CB
    Neuropsychobiology; 1992; 26(1-2):37-42. PubMed ID: 1361969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central tryptamine turnover in depression, schizophrenia, and anorexia: measurement of indoleacetic acid in cerebrospinal fluid.
    Anderson GM; Gerner RH; Cohen DJ; Fairbanks L
    Biol Psychiatry; 1984 Oct; 19(10):1427-35. PubMed ID: 6518200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system receptors in neuropsychiatric disorders.
    Kato G; Ban T
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):207-22. PubMed ID: 6216501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls.
    Pitts AF; Samuelson SD; Meller WH; Bissette G; Nemeroff CB; Kathol RG
    Biol Psychiatry; 1995 Sep; 38(5):330-5. PubMed ID: 7495928
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid corticotropin-releasing hormone in depression: relationship to noradrenergic function.
    Roy A; Pickar D; Linnoila M; Chrousos GP; Gold PW
    Psychiatry Res; 1987 Mar; 20(3):229-37. PubMed ID: 3495811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF beta-endorphin-immunoreactivity in normal, schizophrenic, depressed, manic and anorexic subjects.
    Gerner RH; Sharp B
    Brain Res; 1982 Apr; 237(1):244-7. PubMed ID: 6280804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients.
    Hotta M; Shibasaki T; Masuda A; Imaki T; Demura H; Ling N; Shizume K
    J Clin Endocrinol Metab; 1986 Feb; 62(2):319-24. PubMed ID: 3001125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing factor. From stress to cognition.
    Lightman SL
    Nature; 1995 Nov; 378(6554):233-4. PubMed ID: 7477335
    [No Abstract]   [Full Text] [Related]  

  • 17. Cerebrospinal fluid diazepam binding inhibitor in depressed patients and normal controls.
    Roy A
    Neuropharmacology; 1991 Dec; 30(12B):1441-4. PubMed ID: 1780040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa.
    Gerner RH; Hare TA
    Am J Psychiatry; 1981 Aug; 138(8):1098-101. PubMed ID: 7258390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endorphins in the cerebrospinal fluid of psychiatric patients.
    Pickar D; Naber D; Post RM; van Kammen DP; Kaye W; Rubinow DR; Ballenger JC; Bunney WE
    Ann N Y Acad Sci; 1982; 398():399-412. PubMed ID: 6297360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limbic-hypothalamic-pituitary-adrenal axis activity and ventricular-to-brain ratio studies in affective illness and schizophrenia.
    Risch SC; Lewine RJ; Kalin NH; Jewart RD; Risby ED; Caudle JM; Stipetic M; Turner J; Eccard MB; Pollard WE
    Neuropsychopharmacology; 1992 Feb; 6(2):95-100. PubMed ID: 1319168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.